Replies to post #42292 on RespireRx Pharmaceuticals Inc (RSPI)

[Microlytics]

Definitely silver and I'm not talking about nickels.

My 2021 / 2022 Target for RSPI is $1.25 - 1.75 once they bring their Phase III drug to market. The upside here is OWCP type upside folks. Most have no idea that they have a PHIII drug for OSA in a billion dollar space with no competition. We are all very very very early to the party which means OPPORTUNITY.

Look at OWCP in 2016. It's coming folks.